Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405431 · ClinicalTrials.gov registry record · NA
Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT00405431 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 43 participants.
The verdict
NCT00405431, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.
Interventions
- DRUG Restasis
- DRUG Endura (artificial tears)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00405431
The ClinicalTrials.gov registry entry for NCT00405431 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Restasis is the first listed.
NCT00405431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00405431 about?
NCT00405431 is a clinical study titled "Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?". The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.
What is the current status of trial NCT00405431?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2004-03. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00405431?
The interventions under investigation include: Restasis (DRUG), Endura (artificial tears) (DRUG).
Who is sponsoring clinical trial NCT00405431?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.